We proactively identify opportunities within targeted investment themes.
We invest in well researched internationally sourced early stage technology businesses in which we believe there is the potential for truly super normal returns.
We identify IP backed investment opportunities in our target markets and carry out extensive proprietary due diligence. This approach allows us to choose only those transactions which we believe to be commercially viable and where we can add significant value.
Our strategy is also to build balanced portfolios around novel, disruptive and scalable technologies covering both life science and non life science sectors but with each having the potential to deliver blockbuster like returns.
Once invested, we work closely as shareholders to build the business alongside the founders.